Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty, SI joint fusion.
All companies · Product and company coverage
In 2025, Eminent Spine reported engagement with 6 surgeons and other clinicians in the states MedaRep covers, worth $52K in consulting, speaking, meals and travel for its device products, the most in Michigan ($21K to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Michigan ($21K, 1 engaged), Wisconsin ($12K, 1 engaged), Texas ($11K, 2 engaged), South Carolina ($9,000, 2 engaged).
In the last ten years FDA made 9 decisions for Eminent Spine (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2025 (2). The latest was on 2025-10-07.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 10 |
| Cervical fusion & disc arthroplasty | 6 |
| SI joint fusion | 2 |
| Eminent Spine 3D Lumbar Interbody Fusion Systems |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Eminent Spine.